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ABSTRACT 
Objective: The present study aims to investigate anti-inflammatory, analgesic and antioxidant effects of the hydroacetonic extract (HAE) from 
Wissadula amplissima whole plant and to determine its polyphenol and flavonoid contents. 
Methods: Extraction was achieved by soaking defatted W. amplissima with aqueous acetone solvent. Acute toxicity and pharmacological 
investigations were performed per os and intraperitoneally on Naval Medical Research Institute (NMRI) mice. The carrageenan-induced paw edema 
and the acetic acid-induced writhing tests were used to assess the in vivo anti-inflammatory and analgesic activities. Inhibition of xanthine oxidase 
and lipoxygenase were carried out in vitro using endpoint spectrophotometric assays at 295 nm and 234 nm. 2,2-diphenyl-1-picrylhydrazyl (DPPH), 
Ferric Reducing Antioxidant Power (FRAP), lipid peroxidation and desoxyribose degradation assays were used to point out antioxidant activities of 
extract. Aluminium chloride colorimetric method was used to determine total flavonoids content when and total phenolic content was measured by 
the method Folin-ciocalteu reagent. 
Results: W. amplissima’s HAE exhibited a slight acute toxicity with no lethality observed. Significant (p<0.05) anti-inflammatory and analgesic 
activities were recorded as well as strong inhibitory activities on lipoxygenase and xanthine oxidase. W. amplissima’s HAE also demonstrated 
interesting antioxidant activities particularly in preventing lipid peroxidation. Polyphenol and flavonoid contents were respectively estimated to 
64.33±1.34 mg Gallic Acid Equivalent (GAE) and 35.17±0.77 mg Quercetin Equivalent (QE) per 100 mg of W. amplissima’s HAE. 
Conclusion: HAE of W. amplissima exhibited a promising anti-inflammatory and analgesic potential compared to the reference (acetylsalicylic acid, 
Hydrocortisone, paracetamol) and regarding the inhibition of lipoxygenase and lipid peroxidation. The anti-inflammatory and analgesic activities 
seem to be related to the antioxidant and enzymes inhibitors compounds of the plant extract. 
Keywords: Anti-inflammatory, Antioxidant, Lipoxygenase, Xanthine oxidase, Wissadula amplissima 




Populations of all the continents use plants for their various needs in 
terms of shelter, clothing, food, flavours and fragrances as not the 
least, medicines [1]. The last decade has witnessed a growing 
number of populations who rely on traditional remedies derived 
from medicinal plant and tremendous progress in medicinal plant 
research. This worldwide trend towards the use of natural plant 
remedies has created an enormous need for information about the 
properties and uses of the medicinal plant for the treatment of 
minor ailments to more complex diseases. 
Malvaceae botanical family consists of dicotyledonous plants with at 
least 2300 species in 200 genera [2]. Wissadula amplissima a member 
of this family is present throughout Africa from Cape Verde to Senegal 
and Eritrea to South Africa [3]. In the central region of Burkina Faso, 
species belonging to this family are well known and used by traditional 
practitioners to treat several diseases. Ethnopharmacological studies 
report the use of this species in folk medicine to treat vomiting, severe 
diarrheas, mucosa, skin and bronchus inflammation; inflammatory 
diseases, fever and allergies. The roots of the plant are used to treat 
anemia, hemorrhages and as a fortifying [4]. 
Inflammation is a complex defensive system of the body against any 
aggression. It involves in pathogenesis of diseases including infections, 
cancer, diabetes, atherosclerosis, arthritis. Several mediators such as 
cytokines (TNF α, IL6, IL 1β), free radical (reactive oxygen species 
(ROS), prostaglandins (PGE2) and leukotriene are released during 
inflammation response. Lipoxygenase (LOX) involved leukotriene 
synthesis play an important role in inflammation maintenance [5]. 
Previous biological investigations have demonstrated that methanol 
extract of Wissadula amplissima leaves possess antioxidant properties (2, 
2–diphenyl-1-pricrylhydrazyl method) and anti-inflammatory capacity 
using carrageenan-induced paw edema in chicks [6]. 
In the best of our knowledge, there is no scientific information 
concerning the in vitro anti-inflammatory activities using the enzymatic 
method, in vivo anti-inflammatory activities using carrageenan-induced 
paw edema in mice, the toxicity and analgesic activities of this species. 
The aim of this present study was to investigate anti-inflammatory 
(in vivo and in vitro), analgesic and antioxidant effects of the 
hydroacetonic extract (HAE) from Wissadula amplissima whole plant 
and to determine polyphenol and flavonoids contents.  
MATERIALS AND METHODS 
Plant materials 
The whole plant of Wissadula amplissima var. Rostrata (Shum. and 
Thonn.) R. E. Fries (Malvaceae) was harvested in January 2013 at 
Gampela (25 km, East of Ouagadougou, Burkina Faso). Botanical 
identity was assessed by Professor Jeanne Millogo-Rasolodimby 
from laboratoire de biologie et ecologie vegetale (University of 
Ouagadougou, Burkina Faso) where a voucher specimen (CI: 16884) 
was deposited. Plant material was dried at room temperature, 
pulverized and stored in an airtight bag until use. 
Animals and housing 
Naval medical research institute (NMRI) mice (7 to 8 w old, 25 to 
35g body weight), provided by the animal housing facility of the 
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University of Ouagadougou, were used. Mice were kept in an 
environmentally controlled breeding room (20-25 °C, 75% humidity, 
12 h photoperiod), fed with standard laboratory food and water ad 
libitum. Mice were fasted 17 h before experiments. Investigation at 
animals was conducted in accordance with the official journal of 
european committee in 1991 and approved by the institutional 
committee regarding the care and use of animals for the 
experimental procedure in 2010; CEE509 [7, 8]. 
Chemicals 
Chemicals were from analytical grade. Acetic acid, acetylsalicylic 
acid, allopurinol, carrageenan, dimethylsulfoxide, 2,2-diphenyl-1-
picrylhydrazyl, hydrocortisone, lecithin, 15-lipoxygenase (EC 
1.13.11.12), paracetamol, quercetin, sodium chloride, xanthine and 
xanthine oxidase (EC 1.1.3.22) were purchased from Sigma-Aldrich 
(St. Louis, MO, USA). Ascorbic acid, desoxyribose, ferric trichloride, 
hydrochloric acid, potassium hexacyanoferrate, thiobarbituric acid 
and trichloroacetic acid were supplied by Labosi (Paris, France). 
Boric acid, ethylenediamine tetraacetic acid, gallic acid, linoleic acid, 
sodium carbonate, sodium phosphate dibasic, sodium phosphate 
monobasic, sodium tetraborate, trichloroacetic acid and all solvent 
used were sourced from Prolabo (Paris, France). 
Extract preparation 
Powdered plant material (50 g) was defatted with petroleum ether 
(500 ml) in a soxhlet extractor and then soaked (48 h, 25 °C, 
continuous stirring) in acetone/water (80/20, 500 ml). Extract was 
filtrated, concentrated in a vacuum evaporator (Büchi Rotavapor R-
200) and lyophilized (Telstar Cryodos 50) to get 44.7 g of hydro 
acetone extract (HAE). HAE was stored at 4 °C until use. 
Acute toxicity test 
Acute toxicity was carried out to determinate lethal dose (LD50
Anti-edematous activity 
). 
NMRI mice orally received 500, 1000, 2000, 3000, 5000 mg/kg and 
intraperitoneally 1000 and 1500 mg/Kg of body weight (bw). After 
the administration of extract, the animals were observed for 2 to 72 
h. Then morbidity or mortality and changes in behavior have been 
noted [9]. 
Anti-edematous activity was evaluated according to Winter et al. 
[10]. Seven groups of six mice were randomly used. HAE of 
Wissadula amplissima was administrated per os at 2 different doses 
(200 and 300 mg/kg bw) and intraperitoneally at 150 mg/kg bw to 
sample groups. Control groups received only vehicle (Water per os, 
0.9 % NaCl ip) while reference groups received reference 
compounds (acetylsalicylic acid at 150 mg/kg bw per os, 
hydrocortisone at 10 mg/kg bw ip). One hour later, 50 μl of 
carrageenan (1% in 0.9 % NaCl) was injected under the aponeurosis 
plantar of the hind paw at each mouse. Paw edema volume was 
measured at time intervals of 1 h, 3 h and 5 h after carrageenan 
injection using plethysmometer (model Ugo Basil, n °7141, Italy). 
The anti-edematous activity was evaluated in the percentage of 
reduction of the edema in treated mice compared to negative control 
using the following formula:  
% Inhibition =  
A − B
A
 × 100 
A represents the average difference paw edema volume in the 
negative control group and B represents the average difference of 
paw edema volume in treated groups of mice. 
Analgesic activity 
The analgesic activity was evaluated according to the acetic acid-
induced writhing test as described by Sawadogo et al. [11] with 
minor modifications. Six groups of 6 randomly selected mice were 
used. HAE of Wissadula amplissima was administrated per os at 2 
different doses (200 and 300 mg/kg, bw) and intraperitoneally at 
150 mg/Kg by to sample groups. Control groups received only 
vehicle (Water per os, 0.9 % NaCl ip) while reference group received 
paracetamol (100 mg/kg bw per os). One hour after drug 
administration, mice received 0.6% of acetic acid injection (10 ml/kg 
bw). A number of writhing was recorded within 5 to 20 min after 
acetic acid injection. The analgesic effect was evaluated according to 
the following formula:  
% Inhibition
=  
Number of Writhes(Control)  −  Number of Writhes(Sample) 
Number of Writhes(Control)
 × 100 
Lipoxygenase (LOX) inhibitory activity 
The inhibition of lipoxygenase was assayed according to the 
spectrophotometric method described by Lycklander and Malterud 
[12] with slight modifications. Briefly, 100 µl of enzyme solution 
(200 U/ml) prepared in boric acid buffer (0.2 M; pH 9.0) was mixed 
with 25 µl of HAE of Wissadula amplissima (1 mg/ml in DMSO) and 
then incubated at room temperature for 3 min. Reaction was then 
initiated by the addition of 125 µl of the substrate (250 µM of 
linoleic acid) and the velocity was recorded for 3 min at 234 nm with 
a microplate reader (Epoch, BioTeck instruments, USA). DMSO was 
used as a control while quercetin and ibuprofen were used as 
reference compounds. Percentage of lipoxygenase inhibition was 
calculated according to the equation:  
% Inhibition of lipoxygenase =  
V0Control −  V0Sample
V0Control
 × 100 
V0Control:  Enzymatic activity without inhibitor, V0Sample:  
Xanthine oxidase (XO) inhibitory activity 
Enzymatic 
activity in presence of HAE or reference compounds. 
Xanthine oxidase inhibition was assessed according to the 
spectrophotometric method reported by Filha et al. [13] with slight 
modifications. In brief, 20 µl of enzyme solution (0.28 U/ml in 
phosphate buffer pH 7.5) was mixed with 20 µl of HAE of Wissadula 
amplissima (1 mg/ml in DMSO), 60 µl of phosphate buffer (pH 7.5) 
and then incubated at room temperature for 2 min. The reaction was 
initiated by the addition of 100 µl of the substrate (150 µM of 
xanthine in phosphate buffer) and the velocity was recorded for 3 
min at 295 nm with a microplate reader (Epoch, BioTeck 
instruments, USA). DMSO was used as a control while allopurinol 
was used as reference inhibitor. Percentage of xanthine inhibition 
was calculated according to the equation:  
% Inhibition of xanthine oxidase =  
V0Control −  V0Sample
V0Control
 × 100 
V0Control:  Enzymatic activity without inhibitor, V0Sample:  
DPPH radial scavenging assay 
Enzymatic 
activity in presence of HAE or allopurinol. 
DPPH radical scavenging activity was evaluated as described by 
Kadam et al. [14]. Briefly, 200 µl of freshly prepared DPPH solution 
(0.02 mg/ml in methanol) was mixed with 100 µl of HAE of 
Wissadula amplissima (from 100 to 25 µg/ml in methanol). After 
shaking, the mixture was incubated for 15 min in darkness at room 
temperature and absorbance measured at 517 nm against a blank 
(methanol) with a microplate reader (Epoch, BioTeck instruments, 
USA). Inhibition of DPPH radical was calculated as following:  
% Inhibition of DPPH radical =  
AbsBlank −  AbsSample
AbsBlank
 × 100 
AbsBlank and AbsSample are the absorbances of the blank and sample 
reactions. IC50
Ferric reducing antioxidant power (FRAP) assay 
 (Concentration scavenging 50 % of DPPH radicals) 
was graphically determined. Gallic acid and Quercetin were used as 
positive controls. 
FRAP assay was performed according to Lamien–Meda et al. [15]. 
HAE of Wissadula amplissima (100 µl, 1 mg/ml in methanol) was 
mixed with 250 µl of phosphate buffer (0.2 M, pH 6.6) and 250 µl of 
potassium hexacyanoferrate solution (1% in water). After 30 min of 
incubation (50 ° C), 250 µl of trichloroacetic acid (10% in water) was 
added and the mixture was centrifuged (2000 g for 10 min). The 
supernatant (125 µl) was mixed with water (125 µl) and 25 µl of 
fresh FeCl3 solution (0.1 % in water) and then absorbance was read 
at 700 nm with a microplate reader (Epoch, BioTeck instruments, 
Kiendrebeogo et al. 
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USA). Ascorbic acid was used to plot a calibration curve (R2 = 0.99). 
Reducing power was expressed as mg ascorbic acid equivalent per 
gram of HEA (mg AAE/g). Gallic acid and quercetin were used as 
positive controls. 
Lipid peroxidation inhibition assay 
Inhibition of lipid peroxidation was determined following the 
method described by Kulkarni et al. [16]. Briefly, 100 µl of HAE of 
Wissadula amplissima (from100 to 25 µg/ml in methanol) were 
added to 100 µl of lecithin (10 mg/ml in phosphate buffer 10 mmol, 
pH 7.4), FeCl3 (100 µl; 40 mmol) and ascorbic acid (100 µl; 20 
mmol) for 1 hour incubation at 37 °C. HCl (1 ml, 0.25N) 
supplemented with 15% TCA and 0.375 % TBA was added to the 
mixture, incubated for 15 min at 100 °C and centrifuged (3000 rpm 
for 10 min). The absorbance of the supernatant was read at 532 nm 
against a blank (methanol) with a microplate reader (Epoch, 
BioTeck instruments, USA). Inhibition of lipid peroxidation was 
calculated as following:  
% Inhibition of lipid peroxidation =  
AbsBlank −  AbsSample
AbsBlank
 × 100 
AbsBlank and AbsSample are the absorbances of the blank and sample 
reactions. IC50 (Concentration inhibiting 50 % of lipid peroxidation) 
was graphically determined. Quercetin was used as a positive control. 
Desoxyribose degradation assay 
The ability of HAE of Wissadula amplissima to prevent the 
degradation of the desoxyribose was determined using the method 
described by Houghton et al. [17]. Briefly, freshly prepared 2-
desoxyribose (100 µl, 28 mmol in phosphate buffer 50 mmol, pH 
7.4), EDTA (500 µl; 1.04 mmol), FeCl3 (100 µl; 100 mmol), H2O2 
(100 µl, 1.0 mmol) and ascorbic acid (100 µl, 1.0 mmol) was mixed 
and incubated at 37 °C for 1 hour with HAE (100, µl; 1 mg/ml). 
Thiobarbituric acid (1 ml of 1% aqueous solution) and 
trichloroacetic acid (1 ml of 2.8 % aqueous solution) was added to 
the mixture and incubated at 100 °C for 20 min. The resultant 
mixture was centrifuged (3000 g for 10 min). Absorbance of the 
organic layer containing thiobarbituric acid reactive substances was 
measured at 532 nm against a blank (methanol) with a microplate 
reader (Epoch, BioTeck instruments, USA). Inhibition of 
Desoxyribose degradation was calculated as following:  
% Inhibition of desoxyribose degradation
=  
AbsBlank −  AbsSample
AbsBlank
 × 100 
IC50
Total polyphenol content was determined according to Singleton 
et al. [18]. HAE of W. Amplissima (25 µl, 100 µg/ml in Methanol) 
was mixed with Folin Ciocalteu Reagent (105 µl, 0.2 N) and 5 min 
later with sodium bicarbonate (100 μl, 75 g/l). After 1-hour 
incubation, absorbance was measured at 760 nm against a blank 
with a microplate reader (BioTeck instruments, USA). A standard 
calibration curve (Y = 0.005X+0.00968; R
 (Concentration inhibiting 50 % of desoxyribose degradation) was 
graphically determined. Quercetin was used as a positive control. 
Polyphenol and flavonoids content 
2 = 0.99) was plotted 
using Gallic acid (0-100 mg/l). Polyphenol content was expressed 
as mg of Gallic acid equivalent to 100 mg of extract (mg GAE/100 
mg). 
The total flavonoids content was estimated according to Arvouet–
Grant et al. [19]. HAE of W. amplissima (75 µl, 100 µg/in methanol) 
was mixed with aluminium trichloride (75 µl, 2%in methanol). 
Absorbance was subsequently read at 415 nm after 10 min 
incubation against a blank with a microplate reader (Epoch, BioTeck 
instruments, USA). A standard calibration curve (y = 
0.02891X+0.0036; R2
RESULTS 
 = 0.99) was plotted using Quercetin (0-100 
mg/l). Flavonoid content was expressed as mg of Quercetin 
equivalent to 100 mg of extract (mg QE/100 mg). 
Statistical analysis 
Experiments were carried out in triplicate and results expressed as 
mean±SEM. ANOVA analysis (p<0.05) and linear regression were 
performed with GraphPad Prism 5 and XLSTAT 7.1 software. 
Acute toxicity 
Any mortality was observed at the highest doses of W. amplissima 
HAE (5000 mg/Kg bw per os, 1500 mg/Kg bw intraperitoneally) on 
mice model. However behavioral signs (prostration, loss of 
exploration instinct, sleepiness and feed refusal) were observed 
within two hours following the extract administration per os at 5 
000 mg/kg bw. Although behavioral signs disappear after 2 d and 
mice regain their initial vitality. These results point out that HAE did 
not exhibit any acute toxicity effect on NMRI mice at the doses 
tested. 
Anti-inflammatory activity in vivo 
The anti-inflammatory activity of W. amplissima HEA was assessed 
in vivo through its anti-edematous and analgesic effects as 
summarized in table 1 and table 2. 
Either in oral or intraperitoneal (i. p.) administration, edema 
induced by carrageenan injection was significantly (p<0.05) reduced 
in a time-dependent manner within 5 h after inflammation, that is 
not the case of acetylsalicylic acid administrated per os. In our 
experimental conditions, HEA administrated per os at 200 and 300 
mg/kg bw were less active than acetylsalicylic acid (150 mg/kg bw 
per os) within an hour but were more efficient at the fifth hour. HEA 
(150 mg/kg; i. p.) exhibited the same effect than hydrocortisone (15 
mg/kg) within 3 h, the latter being more effective at the fifth hour. 
Regarding the analgesic activity, reduction of contortions dose-
dependent when HAE is administrated per os. Either in oral (200 and 
300 mg/kg bw) or intraperitoneal (150 mg/kg bw) administration 
HAE was more effective than paracetamol (100 mg/kg, bw, per os). 
Inhibition of lipoxygenase and xanthine oxidase 
Table 3 show that HAE possess significant inhibitory activities on 
both enzymes respectively with 72.80% inhibition for xanthine 
oxidase (XO) and 68.99% inhibition for lipoxygenase (LOX) when 
tested at 100 µg/ml (final concentration). Regarding LOX inhibition, 
HAE is more potent than quercetin (52.97%) but less active than 
ibuprofen (78.61%). Concerning XO inhibition, HEA is slightly 
weaker than quercetin (93.63%) and allopurinol (95.49%). 
 
Table 1: Effect of HAE of W. amplissima on edema induced in mice by the injection of carrageenan 
Samples administration (mg/kg) Volume of edema (ml) Inhibition percentage (%) 
1 h 3 h 5 h 1 h 3 h 5 h 
per os Control (Nacl 0.9%) 0.21±0.04 0.33±0.01 0.36±0,01 --- --- --- 
HAE (200) 0.16±0.01 0.19±0.01* 0.12±0.01* 21.66±3.67 38.36±1.22 65.69±2.69 
HAE (300) 0.13±0.03* 0.23±0.03* 0.07±0.04* 38.09±1.52 48.83±5.68 76.06±4.39 
acetylsalicylic acid (150) 0.10±0.01* 0.16±0.01* 0.15±0.01* 48.47±6.81 50.96±2.37 56.47±4.80 
i. p. Control (Nacl 0.9%) 0.22±0.05 0.36±0.03 0.38±0,02 --- --- --- 
HAE (150) 0.15±0.03 0.22±0.05* 0.20±0.07* 24.85±1.45 35.75±1.6 41.11±2.00 
Hydrocortisone (15) 0.15±0.05* 0.21±0.01* 0.16±0.02* 24.28±2.50 35.95±5.90 53.51±2.80 
Data are expressed as mean values±SEM (n= 6), HAE: Hydro acetone extract of W. amplissima, *Values within the same sub-column harbouring 
asterisk mark in superscript are significantly different from the control group (p<0.05). 
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Table 2: Effect of HAE of W. amplissima against writhing induced by acetic acid 
Samples administration (mg/kg) Number of Writings Inhibition percentage (%) 
per os Control  66.27±6.50 --- 
HAE (200) 28.66±14.75* 56.74±2.41 
HAE (300)  24.66±4.84* 62.78±6.67 
Paracetamol (100) 35.16±2.13* 46.94±2.78 
i. p Control  74.40±3.79 --- 
HAE (150) 47.93±3.67* 47.93±3.67 
Data are expressed as mean values±SEM (n= 6), HAE: Hydro acetone extract of W. amplissima *Values within the same sub-column harboring 
asterisk mark in superscript are significantly different from the control group (p<0.05) 
 
Table 3: Inhibition of xanthine oxidase and lipoxygenase by HAE from W. amplissima 
Samples (µg/ml) Xanthine oxidase inhibition (%) Lipoxygenase inhibition (%)  
HAE (100) 72.80±1.44 68.99±1.39b b 
Allopurinol (100) 95.49±0.47 nd a 




Data are expressed as mean±SEM (n= 3), HAE: Hydro acetone extract of W. amplissima, a-c
 
Antioxidant activity, polyphenol and flavonoid content 
Within the same column, values with different letter in 
superscript are significantly different (p<0.05). 
The antioxidant potential of the HAE of W. amplissima to scavenge 
DPPH radical, to prevent ferric reduction, lipid peroxidation and 
desoxyribosse degradation has been compared with those of 
Quercetin. As shown (table 4), HAE of W. amplissima demonstrates 
an interesting antioxidant potential. Indeed, in the lipid 
peroxidation model, HAE of W. amplissima exhibited the same 
antioxidant activity than quercetin, our antioxidant reference. 
Although HAE of W. amplissima was less active than quercetin in 
the other antioxidant model tested, it ferric reducing power was 
only 1.5 lower than that of quercetin and IC 50
 
values recorded in 
DPPH and desoxyribose assays were lower than 100 µg/ml. Total 
polyphenol and flavonoid content of HAE from W. amplissima were 
respectively 64.33±1.34 GAE/100 mg of extract and 35.17±0.77 
QE/100 mg of extract. 
Table 4: Antioxidant activity, polyphenol and flavonoid content of HAE from W. amplissima 
 Samples 
HAE Quercetin 
DPPH assay (IC50 57.33±2.3, µg/ml) 1.35±0.13b a 
Desoxyribose assay (IC50 32±2.51, µg/ml) 10.06±0.11b 
Lipid peroxidation assay (IC
a 
50 11.9±0.1, µg/ml) 9.13±0.11a 
FRAP assay (µmol AAE/g) 
a 
120.37±2.52 187.77±2.27b 
Polyphenol content (mg GAE/100 mg) 
a 
64.33±1.34 - 
Flavonoid content (mg GAE/100 mg) 35.17±0.77 - 
Data are expressed as mean±SEM (n= 3), HAE: Hydro acetone extract of W. amplissima, a-b: 
 
Within the same line, values harboring different letter in 
superscript are significantly different (p<0.05). 
DISCUSSION 
The present study demonstrated that hydro acetonic extract (HAE) 
of W. amplissima possess potential pharmacological properties 
including antioxidant, anti-edematous, analgesic and inhibiting 
enzymes (xanthine oxidase and lipoxygenase) effects. HAE of whole 
W. amplissima was considered as slightly toxic conferring to toxicity 
scale established by Hodge and Sterner [9], because the LD50
Edema induced by the carrageenan injection is an animal model 
assay commonly used to evaluate the anti-inflammatory activity of 
substances. Carrageenan injection provokes the release of several 
chemical mediators which are the basis of the inflammatory process. 
The inflammatory response is biphasic [20, 21]: the first phase 
lasted one hour that mediated by histamine, serotonin and 
bradykinin; the second phase (above one hour) is due to the 
biosynthesis of prostaglandins [22]. HAE of W. amplissima whole 
plant inhibited the edema in a dose-dependent manner and in all 
these phases. Thus, the extract may have an antagonistic action 
against histamine, bradykinin, serotonin and the prostaglandins 
biosynthesis. The highest value of inhibition was obtained at the fifth 
hour. This suggests that the inhibitor action of the HAE of W. 
amplissima could be acted more on the cyclooxygenases which are 
implicated in the synthesis of prostaglandins. 
 was 
above 5000 mg/kg of body weight. 
The extract was effective as well as it was orally administrated or by 
intraperitoneal injection. The molecular structure plays a key role in the 
choice of the way used to administrate a drug. In this study results 
shown that whatever the administration mode was (orally or 
intraperitoneally) the HAE of W. amplissima was effective. This suggests 
that bioactive compounds, responsible for the anti-inflammatory 
properties found in this herbal mixture have been easily absorbed 
through the intraperitoneal way or via the gastrointestinal mucosa. 
Writhing induced by acetic acid injection is a method used to study the 
peripheral analgesic effect of a substance [23]. Abdominal contortions 
induced by acetic acid injection were used to evaluate the analgesic 
effect of HAE of W. amplissima. Test showed that the extract had a non-
opioid analgesic potential either oral or intraperitoneal 
administration. The pain caused by the injection of acetic acid is due to 
the release of serotonin, bradikynin, substance P and prostaglandins 
(PGE2α et PGF2α
Lipoxygenases (LOXs) play an important role in the biosynthesis of 
leukotrienes which are pro-inflammatory mediators involved in the 
physiopathology of inflammatory diseases. Leukotriene LTB4 is a 
powerful pro-inflammatory chemotactic agent for a variety of 
leukocytes; and leukotrienes (C4, D4, E4) are responsible of vascular 
permeability and smooth muscle contraction [25]. HAE of W. 
amplissima inhibited lipoxygenase; it suggests that extract prevents 
leukotrienes actions inhibiting LOX.  
). These chemical mediators stimulate peripheral 
nociceptive neurons and induce the vascular permeability [24]. HAE of 
W. amplissima inhibited abdominal contraction in a dose-dependent 
manner. Analgesic effect of HAE of W. amplissima could be related to 
the inhibition of these chemical mediators. 
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The enzyme xanthine oxidase (XO) catalyzes the oxidation of 
hypoxanthine and xanthine to uric acid in the purine catabolic 
pathway [26]. Uric acid plays a crucial role in pathogenesis 
hyperuricemia, cardiovascular diseases [27]. HAE of W. amplissima 
whole plant inhibited XO. HAE of W. amplissima whole plant was 
evaluated for its in vitro anti-inflammatory activity by inhibition of 
LOX and XO enzymes. The inhibition of these enzymes is a potential 
therapeutic to treat asthma, hyperuricemia and gout.  
During inflammatory process, excessive production of free radical 
such as reactive oxygen species (ROS) are released causing cells 
lysis, pro-inflammatory cytokines (TNFα, IL1β, IL6) production and 
LOX and cyclooxygenases expression [28]. The inhibitor effect of 
HAE of W. amplissima whole plant against ROS, was evaluated using 
DPPH, desoxyribose degradation assay, FRAP and lipid peroxidation 
methods that were widely used to determine the antioxidant 
capacity of substances. The extract exhibited antioxidant activity 
with four methods, however, its effect was smaller than quercetin. In 
this study different methods were used because it takes more than 
one antioxidant method to assess the mode of action of antioxidants 
[29]. The antioxidant capacity of W. amplissima HAE contributes to 
reinforce its anti-inflammatory effect. 
The results of this study reveal that HAE of W. amplissima contains 
polyphenol and flavonoid compounds which could be responsible of 
evidenced pharmacological activities. 
CONCLUSION 
The present study showed that the hydroacetonic extract of 
Wissadula amplissima possesses antioxidant, analgesic and anti-
inflammatory (in vitro and in vivo) effects. Data obtained represent a 
scientific basis for the traditional use of Wissadula amplissima to 
manage inflammatory diseases. Further bio-guided investigations 
would help in the isolation of compounds and in the clear 
elucidation of their mechanism of action. 
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